국민건강보험 청구 자료를 이용한 국내 의료기관 Clostridioides difficile 감염 추이 분석
The Trend of Clostridioides difficile Infection in Korean Hospitals with the Analysis of Nationwide Sample Cohort
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
배경: Clostridioides (Clostridium) difficile는 항균제를 복용한 환자에서 설사를 동반하는 질환을 일으키는 중요한 병원감염균이지만 국내 감염의 현황은 잘 알려져 있지 않다. 방법: 장기간의 국내 C. difficile 감염 추이를 국민건강보험공단의 표본코호트를 이용하여 분석하였다. 분석에는 사회경제적 변수, 질병 중증도 및 의료기관 특성을 포함하였다. 결과: C. difficile 감염률은 2006년 0.030%에서 2015년 0.317%로 크게 증가하였다. 연령에 따라서도 차이를 보여 50세 미만은 0.033%인데 비해 70-79세 0.412% 및 80세 이상 0.758%로 고령에서 발생률이 높았다. Charlson comorbidity index가 0점이 0.048%인데 비해 3 이상인 경우 0.378%로 감염률은 중증도가 높은 경우 높았다. 의료기관 종별로도 차이를 보여 상급종합병원은 0.270%인데비해 일반병원(정신병원 포함)에서는 0.056%였다. 결론: 고령과 중증도가 높은 환자를 중심으로 국내 C. difficile 감염이 적지 않으며, 꾸준히 증가하고 있음을 알 수 있었다.
Abstract
Background: Clostridioides (Clostridium) difficile is an important pathogen that causes diarrhea in people who take antibiotics. The recent status of C. difficile infection is not wellknown in Korea. Methods: The long-term trend of C. difficile infection in Korean hospitals was analyzed using a nationwide sample cohort. The data also included sociodemographic characteristics, disease severity, and healthcare facilities. C. difficile infection was defined by the prescription of oral vancomycin or all metronidazole prescriptions under C. difficile infectious disease code (A047). Results: The rate of C. difficile infection has steadily increased from 0.030% in 2006 to 0.317% in 2015. The increased rate correlated to age (0.033% for <50 years, 0.421% for 70-79 years, and 0.758% for >80 years of age) and the Charlson comorbidity index score (0.048% for zero versus 0.378% for three or more points). It differed by the type of medical institution (0.270 % at referral hospitals versus 0.056 % at general hospitals and mental hospitals). Conclusion: The rate of C. difficile infection in Korea is significant in patients with advanced age and disease severity. The results show that C. difficile infection trend has been increasing steadily in Korea.
참고문헌 (16)
- Bartlett JG, "Clostridium difficile : history of its role as an enteric pathogen and the current state of knowledge about the organism", Clin Infect Dis, 18, pp.S265~S272 (1994)
- Pepin J. Valiquette L, "Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003 : a changing pattern of disease severity", Can Med Assoc J, 171, pp.466~472 (2004)
- Loo VG, "A predominantly clonal multi-institutional outbreak of Clostridium difficile associated diarrhea with high morbidity and mortality", N Engl J Med, 353, pp.2442~2449 (2005)
- Kim YS, "Incidence and clinical features of Clostridium difficile infection in Korea : a nationwide study", Epidemiol Infect, 141, pp.189~194 (2013)
- Choi HY, "The epidemiology and economic burden of Clostridium difficile infection in Korea", Biomed Res Int, 2015, pp.510386~ (2015)
- Lee J, "Cohort profile : the national health insurance servicenational sample cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- 김경훈, "Charlson 동반질환의 ICD-10 알고리즘 예측력 비교연구", 예방의학회지, 43(1), pp.42~49 (2010), 대한예방의학회
- Quan H, "Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries", Am J Epidemiol, 173, pp.676~682 (2011)
- Martín-Loeches I, "Risks for multidrug-resistant pathogens in the ICU", Curr Opin Crit Care, 20, pp.516~524 (2014)
- Yoon YK, "Trends of antibiotic consumption in Korea according to national reimbursement data (2008–2012): a population-based epidemiologic study", Medicine, 94, pp.e2100~ (2015)
- 김도균, "Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015", Annals of Laboratory Medicine, 37(3), pp.231~239 (2017), 대한진단검사의학회
- Lee H, "Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from KorGLASS", Euro Surveill, 23, pp.1800047~ (2018)
- Byun JH, "A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea", Anaerobe, 60, pp.102106~ (2019)
- Nicholas A, "Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals", PLoS One, 12, pp.e0174716~ (2017)
- Friedman ND, "Healthcareassociated bloodstream infections in adults : a reason to change the accepted definition of community-acquired infections", Ann Intern Med, 137, pp.791~797 (2002)
